about
sameAs
Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamicsThe minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an α-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humansAltered ultrastructural distribution of nephrin in minimal change nephrotic syndrome.The kidney is the principal organ mediating klotho effects.Intentional ABO-incompatible heart transplantation: a case report of 2 adult patients.Renal effects of treatment with a TLR4 inhibitor in conscious septic sheep.Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America.Update on endemic nephropathies.A novel model of adenine-induced tubulointerstitial nephropathy in mice.Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration.Schip1 is a novel podocyte foot process protein that mediates actin cytoskeleton rearrangements and forms a complex with Nherf2 and ezrin.Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients.Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.Liver biopsy interpretation for causes of late liver allograft dysfunction.Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.Meaningful learning: students' perceptions of a new form of case seminar in pathology.Knockdown of Tmem234 in zebrafish results in proteinuria.Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans.Quantitative and three-dimensional aspects of the rat parathyroid gland in normo-, hypo-, and hypercalcemia.Glcci1 deficiency leads to proteinuria.Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation.Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.Pdlim2 is a novel actin-regulating protein of podocyte foot processes.Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome.Correction: Schip1 Is a Novel Podocyte Foot Process Protein that Mediates Actin Cytoskeleton Rearrangements and Forms a Complex with Nherf2 and Ezrin.Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis.Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.Hepatic cell membrane damage during cold preservation sensitizes liver grafts to rewarming injury.Improved histological evaluation of vascularity around an immunoisolation device by correlating number of vascular profiles to glucose exchange.2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model.Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation.The coxsackie and adenovirus receptor (CAR) is required for renal epithelial differentiation within the zebrafish pronephros.Proximal Tubular Expression Patterns of Megalin and Cubilin in Proteinuric Nephropathies.Septal distribution and the relationship of matrix vesicle size to cartilage mineralization.Parathyroid cell number and size in hypocalcemic young rats.To be and to have a critical friend in medical teaching.Emotionally challenging learning situations: medical students' experiences of autopsies.Concentration-guided ribavirin dosing with darbepoetin support and peg-IFN alfa-2a for treatment of hepatitis C recurrence after liver transplantation.
P50
Q24294292-80F4F469-272B-4019-8950-C339C9932DC0Q28289312-1EE4308D-80CD-42FE-A836-D07F3523D1B6Q31121388-D29DFBDD-9A19-4DA1-9E44-AF397BF6D04FQ34260105-c8b1e035-4d61-0693-ad69-54e6c6c37ca3Q34308803-DF3AA5C5-562F-4F1B-847E-B1CC10F4FFBBQ34309172-4CFDF1D9-3430-4262-9DCF-CA1A9D4181D8Q34357274-25FEF73E-0FF9-4E3B-962D-E8BE1D536670Q34414551-A47F4929-6763-4AA2-9C5A-A41EE49DCAF1Q34746952-B90B78D8-1AE7-4FB5-9F20-2E361A6D61DEQ35124219-DA216417-E536-4F87-976F-3DD2471AD87AQ35586454-75B16D3E-16A5-44C9-977E-0037FEB6A7EDQ35675386-C052DFF6-0946-423C-ACD2-B05605390010Q36280331-AE436D7C-CF97-4355-BA2B-C53CBFD2C527Q36548482-7051F5EF-2771-4669-A347-E75BFA772371Q38996938-4259E160-C8F8-4F8F-BA0B-7BA85D163CD8Q39940920-D524BB3D-C911-45B9-AC5F-2ECBC7E5ADE5Q40531714-20165160-690A-41F0-8487-FA40B710640AQ40675472-6ADEBD1A-6F31-4795-A1DB-BA07A6A51DDBQ40957832-832017B9-4F71-446D-9F8A-6293E6BCE25CQ41139237-E07F5D51-DB77-47DB-B1F3-794673FC0A69Q41504212-1F0ABE50-EE50-4C48-8BA4-C3892627A9D1Q42242622-E573F26A-7757-4ACE-A0A4-3D5FD79B680DQ42492571-38378086-77A6-4272-A0B9-8876958EDF8FQ42525941-39A214A6-0F83-49A4-967E-55B5083BFC84Q42559411-21C7CDB3-001A-440B-A037-DFEF93F41EEFQ42951186-285EE036-2CA6-4899-9FEC-3ECC16B2F234Q44351254-619117EE-4EB8-45A0-B694-AD6B1173C7BAQ44647612-5C42C1A0-58AE-4E33-B1ED-055D04A64DFDQ45222560-3E65716C-850E-4FA1-B57C-E4D61F1A9A52Q46360525-50176180-593F-471D-81D2-76E38ACE218DQ46426291-AF5F6155-0F3D-411B-94D7-C2D5B283AEC1Q46470363-D185FEB0-153D-4616-ABA2-310276C8ADC1Q46620882-4F194099-0ECE-4432-B107-EF9122B47A70Q47074232-A0764C1E-2111-447E-9763-01F108CB30FDQ47137208-616454B1-F072-4316-8541-FA82AB42E36AQ47182840-3F0E14C0-C63B-445C-8D22-7F2D07D9BDB2Q47422011-370160D1-7552-4F67-8B50-B4C5D9F35DCCQ48560935-893FF36F-7A48-4DEE-BFD1-F30ADB2A685AQ50053631-7ED6C77C-E368-449E-8600-3A591C69E00FQ50551492-7F572742-08C3-4486-883B-4B314AC4A926
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
professor/överläkare vid Karolinska Institutet
@sv
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Annika Wernerson
@en
Annika Wernerson
@es
Annika Wernerson
@ga
Annika Wernerson
@nl
Annika Wernerson
@sl
Annika Wernerson
@sq
Annika Östman Wernerson
@ast
Annika Östman Wernerson
@sv
type
label
Annika Wernerson
@en
Annika Wernerson
@es
Annika Wernerson
@ga
Annika Wernerson
@nl
Annika Wernerson
@sl
Annika Wernerson
@sq
Annika Östman Wernerson
@ast
Annika Östman Wernerson
@sv
altLabel
Annika Östman Wernerson
@en
prefLabel
Annika Wernerson
@en
Annika Wernerson
@es
Annika Wernerson
@ga
Annika Wernerson
@nl
Annika Wernerson
@sl
Annika Wernerson
@sq
Annika Östman Wernerson
@ast
Annika Östman Wernerson
@sv
P106
P1651
T_Fnk4iImyE
P21
P27
P31
P496
0000-0003-2792-0010
P569
1961-12-20T00:00:00Z